Fluconazole
Histoplasmosis
National Center for Research Resources (NCRR)Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Histoplasmosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Itraconazole National Center for Research Resources (NCRR) | Phase 1/2 | CCC |
Same molecule, other indications
Fluconazole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →